News Focus
News Focus
Followers 47
Posts 5802
Boards Moderated 0
Alias Born 01/27/2012

Re: BAR123 post# 357290

Thursday, 04/14/2022 3:33:05 PM

Thursday, April 14, 2022 3:33:05 PM

Post# of 518776
Thank you for your post Blarcasamine. Im hoping we have been building a very strong core management team, that will be managing and working side by side these new hires) simeoultaneously as data has been proving out in human trials leading to a very efficient transition from an early stage biotech company to a sales producing small Pharma company. Of course if Alzheimer’s is approved we are going to accelerate into a major pharma but none the less I believe Dr. Missling will do the company very well entering into the Autism Spectrum Disorder world advancing through them like a “string of inestimable pearls”!

Cheers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News